15-90231027-G-C
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_006384.4(CIB1):c.466-5C>G variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.268 in 1,613,294 control chromosomes in the GnomAD database, including 66,588 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Consequence
NM_006384.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CIB1 | NM_006384.4 | c.466-5C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000328649.11 | NP_006375.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CIB1 | ENST00000328649.11 | c.466-5C>G | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_006384.4 | ENSP00000333873 | P1 |
Frequencies
GnomAD3 genomes AF: 0.262 AC: 39822AN: 152036Hom.: 6154 Cov.: 32
GnomAD3 exomes AF: 0.336 AC: 84388AN: 251272Hom.: 17495 AF XY: 0.332 AC XY: 45152AN XY: 135826
GnomAD4 exome AF: 0.269 AC: 392589AN: 1461140Hom.: 60426 Cov.: 34 AF XY: 0.273 AC XY: 198261AN XY: 726904
GnomAD4 genome AF: 0.262 AC: 39844AN: 152154Hom.: 6162 Cov.: 32 AF XY: 0.273 AC XY: 20332AN XY: 74386
ClinVar
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 01, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Unidad de Genómica Garrahan, Hospital de Pediatría Garrahan | Jan 24, 2024 | This variant is classified as Benign based on local population frequency. This variant was detected in 64% of patients studied by a panel of primary immunodeficiencies. Number of patients: 56. Only high quality variants are reported. - |
CIB1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Oct 18, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at